- Home
- CORT vs ATI Comparison
CORT vs ATI Comparison
Compare CORT & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- ATI
- Stock Information
- Founded
- CORT 1998
- ATI 1960
- Country
- CORT United States
- ATI United States
- Employees
- CORT N/A
- ATI N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- ATI Steel/Iron Ore
- Sector
- CORT Health Care
- ATI Industrials
- Exchange
- CORT Nasdaq
- ATI Nasdaq
- Market Cap
- CORT 7.1B
- ATI 7.3B
- IPO Year
- CORT N/A
- ATI N/A
- Fundamental
- Price
- CORT $75.08
- ATI $76.31
- Analyst Decision
- CORT Strong Buy
- ATI Strong Buy
- Analyst Count
- CORT 4
- ATI 8
- Target Price
- CORT $142.00
- ATI $73.29
- AVG Volume (30 Days)
- CORT 1.3M
- ATI 2.2M
- Earning Date
- CORT 05-05-2025
- ATI 05-01-2025
- Dividend Yield
- CORT N/A
- ATI N/A
- EPS Growth
- CORT 8.36
- ATI 2.35
- EPS
- CORT 1.14
- ATI 2.76
- Revenue
- CORT $685,446,000.00
- ATI $4,463,600,000.00
- Revenue This Year
- CORT $35.85
- ATI $7.95
- Revenue Next Year
- CORT $35.22
- ATI $8.37
- P/E Ratio
- CORT $65.80
- ATI $27.64
- Revenue Growth
- CORT 30.93
- ATI 6.82
- 52 Week Low
- CORT $25.35
- ATI $39.23
- 52 Week High
- CORT $117.33
- ATI $72.28
- Technical
- Relative Strength Index (RSI)
- CORT 57.68
- ATI 84.22
- Support Level
- CORT $68.86
- ATI $51.80
- Resistance Level
- CORT $73.36
- ATI $75.63
- Average True Range (ATR)
- CORT 3.26
- ATI 2.54
- MACD
- CORT 0.12
- ATI 1.27
- Stochastic Oscillator
- CORT 95.28
- ATI 100.00
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About ATI ATI Inc.
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.